To successfully complete the NET-PD's current ongoing clinical trial. Summary: The Georgia Health Sciences University (GHSU) Movement Disorders Clinic (MDC) is a uniquely qualified and established clinical center for the proposed continuation of a large Phase III, randomized, double-blinded, placebo-controlled clinical trial, which seeks to evaluate the neuroprotective potential of creatine compared with placebo in over 1700 patients. GHSU is seeking support so as to continue all patient follow-up activities necessary for the successful completion of the creatine trial. Follow-up is expected to be completed in 2015. This project is aimed to evaluate the neuroprotective potential of a pharmacological agent designed to slow the progression of PD;the goal set forth by NINDS upon initiation of the NET-PD program. Long-Term Objectives: 1. To delay the progression of PD through the use of medications while maintaining quality of life. 2. Discover indicators of those susceptible to PD and prevent or delay onset of the disease. 3. Ultimately, find a cure for PD.
Parkinson's disease (PD) affects at least half a million Americans. This number is expected to increase over the coming decades as the population ages. This project seeks to find an effective neuroprotective agent, which would slow the progression of PD and substantially reduce PD-related disability for hundreds of thousands of Americans.
| Litvan, Irene; Lees, Peter S J; Cunningham, Christopher R et al. (2016) Environmental and occupational risk factors for progressive supranuclear palsy: Case-control study. Mov Disord 31:644-52 |
| Wills, Anne-Marie A; Elm, Jordan J; Ye, Rong et al. (2016) Cognitive function in 1736 participants in NINDS Exploratory Trials in PD Long-term Study-1. Parkinsonism Relat Disord 33:127-133 |
| Wills, Anne-Marie A; Pérez, Adriana; Wang, Jue et al. (2016) Association Between Change in Body Mass Index, Unified Parkinson's Disease Rating Scale Scores, and Survival Among Persons With Parkinson Disease: Secondary Analysis of Longitudinal Data From NINDS Exploratory Trials in Parkinson Disease Long-term Study 1 JAMA Neurol 73:321-8 |
| Elm, Jordan J; NINDS NET-PD Investigators (2012) Design innovations and baseline findings in a long-term Parkinson's trial: the National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson's Disease Long-Term Study-1. Mov Disord 27:1513-21 |
